Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D-glucose PET in a patient with thymic carcinoid

Respirology. 2007 Nov;12(6):928-30. doi: 10.1111/j.1440-1843.2007.01161.x.

Abstract

We present a case of thymic carcinoid, in which primary and metastatic lesions of lymph nodes and bones could be detected by [(18)F]fluoro-2-deoxy-D-glucose (FDG)-PET, but not by (123)I-meta-iodobenzylguanidine ((123)I-MIBG) SPECT, or by (99m)Tc-methylene diphosphonate ((99m)Tc-MDP) bone scintigraphy. FDG-PET may be a useful tool for managing thymic carcinoids in patients with negative results on (123)I-MIBG SPECT or (99m)Tc-MDP imaging.

Publication types

  • Case Reports

MeSH terms

  • 3-Iodobenzylguanidine
  • Aged
  • Bone Neoplasms / diagnostic imaging*
  • Bone Neoplasms / secondary
  • Carcinoid Tumor / diagnostic imaging*
  • Carcinoid Tumor / pathology
  • Carcinoid Tumor / therapy
  • Fluorodeoxyglucose F18
  • Humans
  • Iodine Radioisotopes
  • Lymphatic Metastasis
  • Male
  • Positron-Emission Tomography*
  • Radiopharmaceuticals
  • Technetium Tc 99m Medronate
  • Thymus Neoplasms / diagnostic imaging*
  • Thymus Neoplasms / pathology
  • Thymus Neoplasms / therapy

Substances

  • Iodine Radioisotopes
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • 3-Iodobenzylguanidine
  • Technetium Tc 99m Medronate